Akt Phosphorylation Is Not Sufficient for Insulin-Like Growth Factor-Stimulated Myogenin Expression but Must Be Accompanied by Down-Regulation of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Phosphorylation

Department of Pediatrics, University of California, San Francisco, San Francisco, California, United States
Endocrinology (Impact Factor: 4.5). 12/2004; 145(11):4991-6. DOI: 10.1210/en.2004-0101
Source: PubMed


IGF-I has a unique biphasic effect on skeletal muscle differentiation. Initially, IGF-I inhibits expression of myogenin, a skeletal muscle-specific regulatory factor essential for myogenesis. Subsequently, IGF-I switches to stimulating expression of myogenin. The mechanisms that mediate this switch in IGF action are incompletely understood. Several laboratories have demonstrated that the phosphatidylinositol-3-kinase/Akt signaling pathway is essential for myogenic differentiation and have suggested that this pathway mediates IGF-I stimulation of myogenin mRNA expression, an early critical step in the differentiation process. These studies, however, did not address concurrent Akt and MAPK/ERK1/2 phosphorylation, the latter of which is also known to regulate myogenic differentiation. In the present study in rat L6E9 muscle cells, we have manipulated ERK1/2 phosphorylation with either an upstream inhibitor or activator and examined concurrent levels of Akt and ERK1/2 phosphorylation and of myogenin mRNA expression in response to treatment with IGF-I. We find that even in the presence of phosphorylated Akt, it is only when ERK1/2 phosphorylation is inhibited that IGF-I can stimulate myogenin mRNA expression. Thus, although Akt phosphorylation may be necessary, it is not sufficient for induction of myogenic differentiation by IGF-I and must be accompanied by a decrease in ERK1/2 phosphorylation.

Download full-text


Available from: Nicki Tiffin, Mar 11, 2014
123 Reads
  • Source
    • "/ p38 signal transduction is inhibited , stretch - induced myogenesis is blocked even though AKT , another essential mediator of myogenesis ( Li et al . , 2000 ) , is activated normally , which is consistent with previous observations in different settings where AKT phosphorylation alone is not sufficient to induce myogenesis ( Wu et al . , 2000 ; Tiffin et al . , 2004 ) . The dependence of stretch activation of p38 on TNF - ␣ and its receptors suggests that mechanical activation of p38 is mediated by TNF - ␣ released into the medium from myoblasts , a process controlled by TACE ( Blobel , 1997 ; Black , 2002 ) . We show for the first time that TACE is dramatically activated by mechanical stimulation "
    [Show abstract] [Hide abstract]
    ABSTRACT: Skeletal muscle responds to mechanical stimulation by activating p38 MAPK, a key signal for myogenesis. However, the mechanotransduction mechanism that activates p38 is unknown. Here we show that mechanical stimulation of myoblasts activates p38 and myogenesis through stimulating TNF-alpha release by TNF-alpha converting enzyme (TACE). In C2C12 or mouse primary myoblasts cultured in growth medium, static stretch activated p38 along with ERK1/2, JNK and AKT. Disrupting TNF-alpha signaling by TNF-alpha-neutralizing antibody or knocking out TNF-alpha receptors blocked stretch activation of p38, but not ERK1/2, JNK or AKT. Stretch also activated differentiation markers MEF2C, myogenin, p21 and myosin heavy chain in a TNF-alpha- and p38-dependent manner. Stretch stimulated the cleavage activity of TACE. Conversely, TACE inhibitor TAPI or TACE siRNA abolished stretch activation of p38. In addition, conditioned medium from stretched myoblast cultures activated p38 in unstretched myoblasts, which required TACE activity in the donor myoblasts, and TNF-alpha receptors in the recipient myoblasts. These results indicate that posttranscriptional activation of TACE mediates the mechanotransduction that activates p38-dependent myogenesis via the release of TNF-alpha.
    Journal of Cell Science 03/2007; 120(Pt 4):692-701. DOI:10.1242/jcs.03372 · 5.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MALTBY et al. (2004) presented a quite simple method to enhance the muscle fibre number of the M. semitendinosus in turkey poult by increasing the temperature between day 9 and 12 of incubation. Turkeys with a higher fibre number seem to have a lower hypertrophic growth to reach comparable meat yields after slaughter. It could be suggested that the reduced hypertrophy can decrease the incidence of deep pectoral myopathies or leg disorders and improve the well-being of the animals. However, it is not clear if the results by MALTBY et al. (2004) could be transferred to the M. pectoralis superficialis and what molecular mechanisms during embryonic myogenesis are influenced by the higher incubation temperature. Therefore in a short review morphological and molecular changes during the embryonic muscle development are presented. Morphological alterations include, for example, the recruitment of myogenic precursor cells from the dermomyotome, the outgrowth of the early muscle masses, the proliferation of the myoblasts or the differentiation of the cells to functional active fibres. In the second chapter the molecular changes in the myogenic cells during muscle development are presented focussing on the involvement of the myogenic regulatory factors (MRF) myf5, MyoD, MRF4 and Myogenin and the regulation of the mitotic cell cycle. The extra cellular signals that influence the myogenesis especially the IGF I-system or the wnt and Sonic Hedgehog signalling pathways are briefly presented. In the last section possible investigations are described to elucidate the thermal effects on the embryonic muscle development.
    Archiv fur Tierzucht 01/2007; 50. · 0.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As derivatives of the Hsp90-inhibitor and tumoricidal agent geldanamycin move into phase II clinical trials, its potential for triggering adverse effects in non-tumor cell populations requires closer examination. In this report, the effect of geldanamycin on the differentiation and survival of C2C12 myoblasts was investigated. Treatment of differentiating C2C12 myoblasts with geldanamycin blocked myogenin expression, inhibited myotubule formation, and led to the depletion of three Hsp90-dependent protein kinases, ErbB2, Fyn, and Akt, and induction of apoptosis. ErbB2 levels declined rapidly, while Fyn and Akt levels decreased at a slower rate. Geldanamycin blocked the interaction of Hsp90 and its "kinase-specific" co-chaperone Cdc37 with Fyn, indicating that Fyn is an Hsp90-dependent kinase. Pulse-chase experiments indicated that geldanamycin caused newly synthesized Akt and Fyn to be degraded rapidly, but geldanamycin had little effect on the turnover rate of mature Fyn and Akt. Curiously, total cellular Src (c-Src) protein levels and the turnover rate of newly synthesized c-Src were unaffected by geldanamycin. While, geldanamycin had no effect on the levels of the putative Hsp90 client protein MyoD expressed in C2C12 cells, geldanamycin disrupted the interaction of Cdc37 with MyoD. Thus, inhibition of Hsp90 caused C2C12 cells to become depleted of multiple signal transduction proteins whose functions are essential for myoblast differentiation, and muscle cell survival, suggesting that geldanamycin derivatives may have the prospective of adversely affecting the physiology of certain sensitive muscle cell populations in vivo.
    Experimental Cell Research 08/2005; 307(1):212-23. DOI:10.1016/j.yexcr.2005.03.003 · 3.25 Impact Factor
Show more